Production (Stage)
Evolutionary Genomics, Inc.
FNAM
$0.0002
-$0.0006-75.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 100.00% | -127.59% | -101.57% | -99.88% | -100.01% |
| Gross Profit | -100.00% | 127.59% | 101.57% | 99.88% | 100.01% |
| SG&A Expenses | -2.84% | -0.73% | 1.15% | 20.88% | 49.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.01% | -44.29% | -15.86% | -8.69% | -0.49% |
| Operating Income | 30.01% | 44.29% | 15.86% | 8.69% | 0.06% |
| Income Before Tax | 30.74% | 40.87% | 13.86% | 5.59% | -3.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.74% | 40.87% | -24.07% | -41.40% | -63.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.74% | 40.87% | -24.07% | -41.40% | -63.20% |
| EBIT | 30.01% | 44.29% | 15.86% | 8.69% | 0.06% |
| EBITDA | 46.01% | 57.86% | 26.49% | 25.96% | 25.55% |
| EPS Basic | 33.21% | 41.07% | -19.17% | -36.45% | -54.64% |
| Normalized Basic EPS | 38.46% | 47.36% | 17.79% | 8.88% | 0.26% |
| EPS Diluted | 33.74% | 41.42% | -18.01% | -37.23% | -55.88% |
| Normalized Diluted EPS | 38.46% | 47.36% | 17.29% | 8.28% | -0.46% |
| Average Basic Shares Outstanding | 9.81% | 6.51% | 3.56% | 0.36% | 0.32% |
| Average Diluted Shares Outstanding | 9.81% | 6.51% | 2.41% | -0.75% | -0.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |